Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nigel Irwin

Showing results (111-120 of 161) with videos related to

Pageof 17
Sort By:
Diabetologia|December 23, 2016
An enzymatically stable GIP/xenin hybrid peptide restores GIP sensitivity, enhances beta cell function and improves glucose homeostasis in high-fat-fed miceAnnie Hasib, Ming T Ng, Victor A Gault, et al.
Diabetes, Obesity & Metabolism|November 7, 2019
Peptide YY (1-36) peptides from phylogenetically ancient fish targeting mammalian neuropeptide Y1 receptors demonstrate potent effects on pancreatic β-cell function, growth and survivalRyan A Lafferty, Neil Tanday, Andrew McCloskey, et al.
American Journal of Physiology. Endocrinology and Metabolism|September 13, 2007
GIP receptor antagonism reverses obesity, insulin resistance, and associated metabolic disturbances induced in mice by prolonged consumption of high-fat dietPaula L McClean, Nigel Irwin, Roslyn S Cassidy, et al.
Experimental Gerontology|December 28, 2005
Stable agonist of glucose-dependent insulinotropic polypeptide (GIP) restores pancreatic beta cell glucose responsiveness but not glucose intolerance in aging miceNigel Irwin, Brian D Green, Victor A Gault, et al.
The Journal of Pharmacy and Pharmacology|April 23, 2024
Dopamine signalling in pancreatic islet cells and role in adaptations to metabolic stressAnanyaa Sridhar, Peter R Flatt, Matthew Draper, et al.
Diabetes, Obesity & Metabolism|October 11, 2023
Sustained metabolic benefits of ΔTRTX-Ac1, a tarantula venom-derived peptide, when administered together with exenatide in high-fat fed miceAimee Coulter-Parkhill, Neil Tanday, Diego Cobice, et al.
Diabetes, Obesity & Metabolism|March 16, 2026
Unimolecular GLP-1/Apelin Hybrid Peptides Cause Prominent Appetite Suppression, as Well as Enhancing Insulin Secretion, Beta-Cell Survival and Glycaemic RegulationAnanyaa Sridhar, Ethan S Palmer, Sarah L Craig, et al.
Clinical Medicine Insights. Endocrinology and Diabetes|October 22, 2025
Effect of Multiparity on Pregnancy-Induced Islet Adaptation and Cellular TransdifferentiationVaibhav Dubey, Neil Tanday, Asif Ali, et al.
Pancreas|June 19, 2007
Effects of subchronic treatment with the long-acting glucose-dependent insulinotropic polypeptide receptor agonist, N-AcGIP, on glucose homeostasis in streptozotocin-induced diabetesVictor A Gault, Paula L McClean, Nigel Irwin, et al.
Peptides|May 30, 2024
Chronic exposure to incretin metabolites GLP-1(9-36) and GIP(3-42) affect islet morphology and beta cell health in high fat fed miceAnanyaa Sridhar, Dawood Khan, Gayathri Babu, et al.
Pageof 17

Showing results (111-120 of 161) with videos related to

Sort By:
Pageof 17
Diabetologia|December 23, 2016
An enzymatically stable GIP/xenin hybrid peptide restores GIP sensitivity, enhances beta cell function and improves glucose homeostasis in high-fat-fed miceAnnie Hasib, Ming T Ng, Victor A Gault, et al.
Diabetes, Obesity & Metabolism|November 7, 2019
Peptide YY (1-36) peptides from phylogenetically ancient fish targeting mammalian neuropeptide Y1 receptors demonstrate potent effects on pancreatic β-cell function, growth and survivalRyan A Lafferty, Neil Tanday, Andrew McCloskey, et al.
American Journal of Physiology. Endocrinology and Metabolism|September 13, 2007
GIP receptor antagonism reverses obesity, insulin resistance, and associated metabolic disturbances induced in mice by prolonged consumption of high-fat dietPaula L McClean, Nigel Irwin, Roslyn S Cassidy, et al.
Experimental Gerontology|December 28, 2005
Stable agonist of glucose-dependent insulinotropic polypeptide (GIP) restores pancreatic beta cell glucose responsiveness but not glucose intolerance in aging miceNigel Irwin, Brian D Green, Victor A Gault, et al.
The Journal of Pharmacy and Pharmacology|April 23, 2024
Dopamine signalling in pancreatic islet cells and role in adaptations to metabolic stressAnanyaa Sridhar, Peter R Flatt, Matthew Draper, et al.
Diabetes, Obesity & Metabolism|October 11, 2023
Sustained metabolic benefits of ΔTRTX-Ac1, a tarantula venom-derived peptide, when administered together with exenatide in high-fat fed miceAimee Coulter-Parkhill, Neil Tanday, Diego Cobice, et al.
Diabetes, Obesity & Metabolism|March 16, 2026
Unimolecular GLP-1/Apelin Hybrid Peptides Cause Prominent Appetite Suppression, as Well as Enhancing Insulin Secretion, Beta-Cell Survival and Glycaemic RegulationAnanyaa Sridhar, Ethan S Palmer, Sarah L Craig, et al.
Clinical Medicine Insights. Endocrinology and Diabetes|October 22, 2025
Effect of Multiparity on Pregnancy-Induced Islet Adaptation and Cellular TransdifferentiationVaibhav Dubey, Neil Tanday, Asif Ali, et al.
Pancreas|June 19, 2007
Effects of subchronic treatment with the long-acting glucose-dependent insulinotropic polypeptide receptor agonist, N-AcGIP, on glucose homeostasis in streptozotocin-induced diabetesVictor A Gault, Paula L McClean, Nigel Irwin, et al.
Peptides|May 30, 2024
Chronic exposure to incretin metabolites GLP-1(9-36) and GIP(3-42) affect islet morphology and beta cell health in high fat fed miceAnanyaa Sridhar, Dawood Khan, Gayathri Babu, et al.
Pageof 17